Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
Avidity Biosciences (RNA) Stock Price & Analysis
130 Followers
RNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.83 - $25.74
Previous Close$11.15
Volume639.72K
Average Volume (3M)1.34M
Market Cap
$789.63M
Enterprise Value$1.15B
Total Cash (Recent Filing)$118.71M
Total Debt (Recent Filing)$477.69M
Price to Earnings (P/E)-3.3
Beta0.93
Next Earnings
Aug 08, 2023EPS Estimate
-$0.79Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.36
Shares Outstanding70,819,170
10 Day Avg. Volume867,657
30 Day Avg. Volume1,335,996
Standard Deviation0.21
R-Squared0.00059
Alpha-0.00849
Financial Highlights & Ratios
Price to Book (P/B)1.35
Price to Sales (P/S)353.62
Price to Cash Flow (P/CF)-3.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue118.88
Enterprise Value/Gross Profit124.53
Enterprise Value/Ebitda-5.95
Forecast
1Y Price Target
$32.40Price Target Upside187.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Avidity Biosciences News
Stock Analysis & Ideas3 Best Stocks to Buy Now, 5/22/2023, According to Top Analysts
Pre-EarningsRNA Earnings this Week: How Will it Perform?
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RNA FAQ
What was Avidity Biosciences Inc’s price range in the past 12 months?
Avidity Biosciences Inc lowest stock price was $9.83 and its highest was $25.74 in the past 12 months.
What is Avidity Biosciences Inc’s market cap?
Currently, no data Available
When is Avidity Biosciences Inc’s upcoming earnings report date?
Avidity Biosciences Inc’s upcoming earnings report date is Aug 08, 2023 which is in 63 days.
How were Avidity Biosciences Inc’s earnings last quarter?
Avidity Biosciences Inc released its earnings results on May 09, 2023. The company reported -$0.74 earnings per share for the quarter, beating the consensus estimate of -$0.838 by $0.098.
Is Avidity Biosciences Inc overvalued?
According to Wall Street analysts Avidity Biosciences Inc’s price is currently Undervalued.
Does Avidity Biosciences Inc pay dividends?
Avidity Biosciences Inc does not currently pay dividends.
What is Avidity Biosciences Inc’s EPS estimate?
Avidity Biosciences Inc’s EPS estimate is -$0.79.
How many shares outstanding does Avidity Biosciences Inc have?
Avidity Biosciences Inc has 70,819,170 shares outstanding.
What happened to Avidity Biosciences Inc’s price movement after its last earnings report?
Avidity Biosciences Inc reported an EPS of -$0.74 in its last earnings report, beating expectations of -$0.838. Following the earnings report the stock price went up 0.26%.
Which hedge fund is a major shareholder of Avidity Biosciences Inc?
Among the largest hedge funds holding Avidity Biosciences Inc’s share is RA Capital Management. It holds Avidity Biosciences Inc’s shares valued at 99M.
---
Avidity Biosciences Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$32.40 (187.74% Upside)
$32.40 (187.74% Upside)
Blogger Sentiment
Bullish
RNA Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.5%
Last 30 Days ▲ 16.3%
Last 30 Days ▲ 16.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.68%
12-Months-Change
Fundamentals
Return on Equity
-41.12%
Trailing 12-Months
Asset Growth
45.79%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Avidity Biosciences Inc
Avidity Biosciences Inc is a bio-technology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.
---
Top 5 ETFs holding RNA
iShares Biotechnology ETF
$4.87M
Vanguard Health Care ETF
$2.29M
iShares Core S&P Total U.S. Stock Market ETF
$768.44K
Schwab U.S. Broad Market ETF
$381.19K
iShares NASDAQ US Biotechnology UCITS ETF
$367.71K
Up to five ETFs with an Outperform Smart Score that hold RNA. The ETFs are listed according to market value of RNA within the ETF
---
Arcturus Therapeutics
―
Arrowhead Pharmaceuticals
―
BioNTech SE
―
Crispr Therapeutics AG
―
---